| Home | E-Submission | Sitemap | Contact us |  
top_img
Asian J Beauty Cosmetol > Volume 22(3); 2024 > Article
생물전환된 소태나무 추출물의 항염증 및 신생혈관 억제효과: NF-κB 신호전달 경로 억제와 신생혈관 억제에 대한 연구

요약

목적

본 연구는 생물전환된 소태나무 추출물(B-P.Q)의 항염증 및 신생혈관 억제 특성을 비생물전환 추출물(P.Q) 및 작약 뿌리 추출물(BOT)과 비교하는 것을 목적으로 하였다.

방법

본 연구는 NIH 3T3 섬유아세포에 대한 세포 생존력 분석, NF-κB 관련 신호전달 단백질 활성화 측정, CAM 분석, 혈관 형성 분석, HUVEC 세포를 이용한 세포 이동 억제 분석 등 다양한 실험 기법을 활용하였다. 이러한 방법들은 추출물의 세포독성, 항염증 효과, 신생혈관 억제 특성을 평가하는 데 사용되었다.

결과

B-P.Q는 효능 농도에서 세포독성을 보이지 않았으며, P.Q와 BOT에 비해 NF-κB 관련 신호전달 단백질(p-p38, p-Akt-1, p-SAPK/JNK, p-MEK1/2, p-IκB)의 활성화를 억제하는 경향을 나타내었다. 신생혈관 실험에서 B-P.Q는 CAM 분석에서 새로운 혈관 형성을 더 우수하게 억제하였고, 대조군과 P.Q에 비해 HUVEC 이동을 유의미하게 억제하였다.

결론

본 연구는 생물전환된 소태나무 추출물(B-P.Q)이 강력한 항염증 및 혈관신생 억제 특성을 가지고 있으며, 다양한 실험 모델에서 비생물전환 P.Q와 BOT보다 일관되게 우수한 성능을 보였음을 발견하였다. 이러한 결과는 B-P.Q가 특히 과도한 신생혈관을 동반하는 만성 염증 상태에 대한 개선제로서 상당한 가능성을 가지고 있음을 시사한다. 본 연구는 천연 추출물의 생리활성 특성을 향상시키는 데 있어 생물전환의 효과를 강조하며, 염증성 피부 문제에 대한 새로운 피부 개선제 개발 가능성을 제시한다.

Abstract

Purpose

This study aimed to compare the anti-inflammatory and anti-angiogenic properties of bioconverted Picrasma quassioides extract (B-P.Q) with those of the non-bioconverted extract (P.Q) and peony root bark extract (BOT).

Methods

The research utilized several experimental techniques, including cell viability assays on NIH 3T3 fibroblasts, measurement of NF-κB-related signaling protein activation, chorioallantoic membrane (CAM) assays, tube formation assays, and cell migration inhibition assays using human umbilical vein endothelial cells (HUVECs). These methods were employed to evaluate cytotoxicity, anti-inflammatory effects, and anti-angiogenic properties of the extracts.

Results

B-P.Q demonstrated no cytotoxicity at the tested concentrations and significantly inhibited the activation of NF-κB-related signaling proteins (p-p38, p-Akt-1, p-SAPK/JNK, p-MEK1/2, and p-IκB) compared to P.Q and BOT. In angiogenesis experiments, B-P.Q showed superior inhibition of new blood vessel formation in CAM assays, effectively suppressed tube formation, and significantly inhibited HUVEC migration compared to controls and P.Q.

Conclusion

The study found that bioconverted Picrasma quassioides extract (B-P.Q) has strong anti-inflammatory and anti-angiogenic properties, consistently outperforming non-bioconverted P.Q and BOT in various experimental models. These results suggest that B-P.Q holds significant promise as a therapeutic agent for chronic inflammatory conditions, particularly those involving excessive angiogenesis. The research underscores the effectiveness of bioconversion in enhancing the bioactive properties of natural extracts and opens up new possibilities for developing treatments for inflammatory skin problems.

中文摘要

目的

本研究旨在比较生物转化苦木提取物(B-P.Q)与非生物转化提取物(P.Q)和牡丹根皮提取物(BOT)的抗炎和抗血管生成特性。

方法

该研究采用了多种实验技术,包括 NIH3T3成纤维细胞的细胞活力测定、NF-κB 相关信号蛋白激活的测量、绒毛尿囊膜(CAM)测定、管形成测定以及使用人脐静脉内皮细胞的细胞迁移抑制测定细胞(HUVEC)。这些方法用于评估提取物的细胞毒性、抗炎作用和抗血管生成特性。

结果

B-P.Q在测试浓度下没有细胞毒性,与P.Q和BOT相比,显着抑制NF-κB相关信号蛋白(p-p38、p-Akt-1、p-SAPK/JNK、p-MEK1/2 和p-IκB)的激活。在血管生成实验中,与对照和P.Q相比,B-P.Q在CAM 测定中表现出对新血管形成的卓越抑制作用,有效抑制管形成,并显着抑制 HUVEC 迁移。

结论

研究发现,生物转化的苦木提取物(B-P.Q)具有很强的抗炎和抗血管生成特性,在各种实验模型中始终优于未生物转化的P.Q和BOT。这些结果表明,B-P.Q作为慢性炎症疾病(尤其是涉及过度血管生成的慢性炎症疾病)的治疗剂具有重大前景。该研究强调了生物转化在增强天然提取物的生物活性方面的有效性,并为开发炎症性皮肤问题的治疗方法开辟了新的可能性。

Introduction

The cosmetics industry is seeing increased demand for high-performance products, beauty foods, fermented cosmetics, and natural ingredient formulations. This trend aligns with a growing focus on healthier lifestyles and enhanced beauty. In response, there’s active development in natural formulations, cellular research, and clinical trials. Popular ingredients like green tea catechins, isoflavones, and curcumin are favored for their skin benefits, with ongoing research exploring new natural ingredients to further improve cosmetics (Lee, 2007).
There is a growing emphasis on eco-friendly wellness trends that prioritize natural ingredients over synthetic ones, driving significant research and development of new materials. Key initiatives include producing cosmetic raw materials from enzymes derived from natural sources and utilizing fermentation techniques with microorganisms for bioconversion, all aimed at promoting sustainability and eco-friendliness in product development (Pérez-Rivero & López-Gómez, 2023).
The fermented cosmetics market in South Korea is growing rapidly, leveraging traditional fermentation techniques from food processing to extract specific components with minimal nutrient loss. These components are then incorporated into cosmetics to improve absorption and effectiveness. Commonly used ingredients include plum, honey, red ginseng, polyphenols, yeast, soybean, moringa leaf, probiotics, and Bacillus-fermented extracts. Meanwhile, industries like food quality enhancement and pharmaceuticals employ microbial protein-degrading enzymes such as Actinidin, Ficin, Bromelain, and Papain— found in fruits like kiwi, pear, pineapple, papaya, and fig— for purposes like meat tenderization. Despite the large scale of the domestic cosmetics market in Korea, it lags behind the pharmaceutical industry in adopting advanced technologies, with more than half of its raw materials being imported. As a result, there is a strong need for ongoing research and development in domestic cosmetic raw materials through biotechnology (Chen et al., 2018).
It plays a vital role in activating the immune system and facilitating wound healing, focusing on the damaged area and utilizing advanced defense mechanisms to restore it to its normal state. This process is crucial in the occurrence of various diseases (Strbo et al., 2014). Mast cells, when activated by external invaders during inflammatory responses, produce a range of inflammatory mediators that create defense mechanisms to eliminate antigens effectively. However, if these mediators continue to increase, they can lead to chronic inflammatory skin conditions. Therefore, it is essential to suppress the inflammatory response that generates these mediators (Lundberg, 2000). Antiinflammatory agents that suppress the excessive activity of inflammatory mediators have been extensively studied for treating chronic inflammatory skin conditions. However, research on skin side effects and resistance remains limited, highlighting the need for substantial efforts to develop natural substances with anti-inflammatory properties that can effectively address various inflammatory conditions (Ginwala et al., 2019).
As a result, ongoing research efforts, both domestically and internationally, are focused on discovering materials through the bioconversion of natural and plantbased sources. However, studies on bioconverting plant materials like the bark of Picrasma quassioides using plant-derived enzymes from pineapple and kiwi remain limited. Additionally, research on natural substances with anti-inflammatory effects, which could address various inflammatory conditions, is also underexplored. Therefore, this study aims to investigate the enhanced anti-inflammatory properties of bioconverted Picrasma quassioides bark using enzymes derived from pineapple and kiwi.
Picrasma quassioides, widely found in Korea, Taiwan, Japan, China, and India, belongs to the dicotyledonous plant order Sapindales and the family Simaroubaceae. It is a deciduous hardwood tree that grows up to about 10 meters in height, with leaves less than 10 cm long, arranged in feather-like clusters of 10-14 leaflets. The tree produces greenish-yellow flowers, approximately 5-8 mm in diameter, that typically bloom separately as male and female flowers in June. Male flowers have around five divided stamens, while female flowers contain about five pistils. Known for its resilience to dryness and cold, Picrasma quassioides has dense, hard wood commonly referred to as “bitterwood”, Traditionally, it has been used to treat tonsillitis, pharyngitis, and eczema (Mohd Jamil et al., 2020). Traditionally, the woody parts of Picrasma quassioides are harvested, dried, and then commonly used. In China, the stems and root bark from Picrasma quassioides, known as “high tree bark”, are believed to have effects similar to those of bitterwood. Picrasma quassioides contains carbohydrates, fat, and ash, with notably higher levels of protein and fat compared to other plants. The main components of Picrasma quassioides include quassinoids, tirucallanes, ionones, and alkaloids. The fruits of Picrasma quassioides are rich in compounds such as arbutin, phlorin, koaburaside, syringin, citrusin B, cnidioside B, flavaprenin 7,4-diglucoside, phenylpropanoids, and phenolic compounds (Yoshikawa et al., 1995). The Simaroubaceae family, to which Picrasma quassioides belongs, is known for its anticancer activity and immunemodulating effects, as well as its anti-inflammatory, antioxidant, anti-hypertensive, and detoxifying properties.
Bioconversion is a technology that uses microorganisms, enzymes, and biological agents to transform precursor substances into desired products or enhance specific components. This process includes bioprocessing, biocatalysis, and biosynthesis, aiming to improve ingredient efficacy and convert prodrugs into active drugs with better bioavailability (Bae et al., 2004). At its core, bioconversion leverages the functions of living organisms to create new bioproducts or replace traditional chemical processes with biological alternatives. It’s an innovative and environmentally friendly technology designed for modern needs (Willke & Vorlop, 2004).
Traditional fermentation has long relied on simple raw materials to create products, but bioconversion takes a different approach. By harnessing the power of microorganisms and enzymes, bioconversion transforms precursor substances into entirely new compounds. This advanced and energy-efficient technology has the potential to revolutionize industries such as pharmaceuticals, cosmetics, and food development, leading to more effective and innovative solutions.
In this study, we focus on Picrasma quassioides, exploring whether bioconversion can unlock its potential as a functional cosmetic ingredient. Through this process, we aim to discover new ways to enhance the effectiveness of cosmetics, pushing the boundaries of what’s possible in the field.

Methods

1. Picrasma quassioides, kiwi, pineapple

The Picrasma quassioides used in the experiment was bought in dried form from an herbal market in Jecheon, Chungbuk. To eliminate foreign substances and impurities, the bark was washed three times with cold water, then dried with hot air at 60℃, and ground into a powder using a mixer. Pineapple (from the Philippines) and kiwi (from Jeju Island), which were used as sources of plant enzymes, were purchased from a major domestic store. The skins of the pineapple and kiwi were removed, cut into suitable sizes, ground with a mixer, and then homogenized for use. The peony root bark extract used as a control (from Jecheon, Chungbuk) was prepared using the same method as Picrasma quassioides, with the exception of pineapple and kiwi.

2. Reagents and equipments

The extraction process utilized a HEATING MANTLE (USA, MS-DMB605) and a LAB STIRRER (USA, MS5060). The Sandwich ELISA Kit, obtained from Cell Signaling Technology (USA), targeted the following proteins: p-p38 alpha (Thr180/Tyr182), p-Akt-1 (Ser473), p-SAPK/JNK (Thr183/Tyr185), p-MEK1/2 (Ser217/221), p-Stat3 (Tyr705), p-NF-κB, and p-IκB-α (Ser32). Fetal bovine serum (FBS) from Sigma (USA), DMEM medium from Sigma (USA), and Hygromycin B from Roche (Germany) were used. Additional materials included Antibiotic-Antimycotic from Sigma (USA), MTS samples from Promega using the CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay kit (Cat. NO. G5421), and filter paper from Whatman International Ltd., Maidstone (England). All other reagents were of premium or first-grade quality.

3. Bioconversion conditions

Preparation of Picrasma quassioides Bark enzyme reaction mixture (B-P.Q): The enzyme reaction mixture was prepared by blending 100 g of pulverized Picrasma quassioides bark powder with 10-100 g of pulverized kiwi (1-10% in water) and 10-100 g of pulverized pineapple (1-10% in water). NF-κB inhibition experiments were conducted to determine the optimal reaction ratio and duration for these ingredients. It was found that the ideal conditions for biological transformation were 10% Picrasma quassioides bark extract combined with 2% kiwi and 2% pineapple for 7 days. The reaction mixture was then filtered and freeze-dried to obtain B-P.Q for further use. For the Picrasma quassioides extract (P.Q), which included the same proportions of Picrasma quassioides bark, kiwi, and pineapple, the mixture was not incubated for 7 days. Instead, the filtrate was directly frozen and freeze-dried.

4. Cell culture conditions

The NIH 3T3 fibroblast cell line, derived from mice and obtained from Signosis, was seeded in 75T flasks and cultured at 37℃ with 5% CO2. The culture medium consisted of Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma, USA) supplemented with 10% Fetal Bovine Serum (FBS, Sigma, USA), 1% Antibiotic-Antimycotic (Sigma, USA), and 1% Growth Supplement. The medium was changed every 3 days. Cells were passaged when they reached approximately 80-90% confluency, and experiments were performed using cells that had undergone at least one passage to ensure stability.

5. MTS assay

The NIH 3T3 cell line was seeded into 96-well plates at a density of 4×104 cells/mL in 200 μL per well and incubated at 37℃ with 5% CO2 for 24 hours to stabilize. After stabilization, samples were treated with concentrations ranging from 1 mg/mL to 5 μg/mL for 72 hours (3 days) at 37℃ under 5% CO2. PBS, used in the same volume as the samples, served as the control. The MTS assay was conducted using the CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay Kit (Cat. No. G5421) from Promega. MTS solution mixed with PMS solution was added to each well at 20 μL per well and incubated for 1 hour at 37℃ with 5% CO2. Absorbance was then measured at 492 nm using an ELISA reader (Molecular Devices, USA).

6. Measurement of NF-κB

We used the NF-κB Luciferase reporter NIH 3T3 stable cell line from Signosis. The cells were cultured in DMEM media with Hygromycin (100 μg/mL, Sigma) at 37℃ with 5% CO2 to maintain vector integrity. Cells were counted to a density of 5×105 cells/mL, and 100 μL were seeded into 96-well plates and incubated for 24 hours. The samples were then treated as specified. After 12 hours, cells were stimulated with 20 μg/mL TNF-α and 10 μg/mL IL-1β, and harvested 8 hours later. To measure NF-κB activity, cell culture supernatants were removed, and cells were lysed with lysis buffer to extract intracellular Luciferase. Luciferase activity was assessed using a Luminoskan Ascent luminometer (Thermo Electron, USA).

7. Measurement of NF-κB-related signaling proteins activity

The mouse-derived fibroblast cell line 3T3 was used for measuring NF-κB-related cytokines. Cells were seeded at a density of 5×105 cells/mL in 96-well plates, with 100 μL per well, and incubated for 24 hours. After this period, samples were treated. TNF-α (20 μg/mL) and IL-1β (10 ng/mL) were added to induce NF-κB and related signaling pathways. NF-κB-related cytokines were measured at 5, 10, 20, 40, and 80 minutes using a Sandwich ELISA kit (Cell Signaling, USA), as detailed in Table 1, to assess the activity of phosphorylated signaling proteins. The experiment was conducted following the instructions provided in the manual.

8. CAM (Chorioallantoic Membrane) Assay

To assess the ability to inhibit angiogenesis, we used fertilized eggs (Pulmuone, Korea) purchased from a local agricultural cooperative in Wonju, all less than two days post-hatch. A fertilized egg is identified by visible blood vessels and a heartbeat when a window is created. After acquisition, the eggs were incubated at 37℃ with 80-90% humidity. Three days later, a small hole was made at the narrow end of the eggshell membrane, and 4-5 mL of albumin was withdrawn using a 5 mL syringe. The puncture site was sealed to prevent infection and drying, and the eggs were re-incubated with the hole facing downward. Four days later, a 2-3 cm diameter window was created at the air sac end of the egg. Only those eggs confirmed as fertilized were sealed with cellophane tape and re-incubated. Five days after this, when the CAM (chorioallantoic membrane) region had developed and was approximately 2-5 mm in diameter, 5 μg samples were applied to quartered Thermanox coverslips and air-dried overnight in a clean bench to avoid contamination. The tape covering the window was removed, the CAM region was identified, and the Thermanox coverslip with the sample was placed on the CAM region using tweezers. The window was then resealed with cellophane tape. After seven days, the tape was removed, and 1 mL of Intralipose (fat emulsion) was drawn into a syringe, air bubbles were removed, and it was injected just below the CAM to highlight blood vessels against a white background. Angiogenesis inhibition was observed and documented with close-up photographs using a digital camera (Auerbach et al., 2003).

9. Tube Formation (HUVECs Differentiation) Assay

Human umbilical vein endothelial cells (HUVECs) used in the experiment were obtained from MCTT Co., Ltd. The primary cultured cells were grown in plates coated with 0.1% gelatin, using endothelial cell medium (Innoprot, ES) supplemented with 3 ng/mL βFGF, 5 units/mL heparin, and 20% FBS, and were maintained under 5% CO2 at 37℃. The tube formation assay, which assesses HUVEC differentiation, followed a modified method based on Grant et al. (Grant, Kinsella et al. 1992). BD MatrigelTM Basement Membrane Matrix (BD Biosciences, Cat. No. 354230) was applied to a 24-well plate, 100 μL per well, and allowed to coat at 37℃ for 30 minutes. The endothelial cells were then mixed with endothelial cell medium (Innoprot, ES) containing 5% FBS, 2 ng/mL βFGF, and 2 ng/mL EGF, and 450 μL of this mixture was added to each well to achieve a density of 3.6×104 cells per well. The B-P.Q ingredient was added to achieve a final concentration of 50 μg/mL, while the control group received medium containing only 5% FBS. The cells were incubated at 37℃ with 5% CO2 for 18-24 hours, and tube formation was observed under a microscope (Olympus IX53, 100x magnification).

10. HUVECs Cell Migration Inhibition Assay

This experiment used a modified method based on Jang et al (Jiang et al., 2017). HUVECs were seeded at a density of 1×105 cells per well in a 6-well plate and incubated at 37℃ with 5% CO2 for 15 hours to allow stabilization. After 15 hours, a scratch was made on the cell monolayer using a yellow tip. The cells were then washed with PBS and replaced with fresh medium. The control group was provided with medium containing 5% FBS, while the other groups received 180 μL of medium containing 5% FBS, 2 ng/mL βFGF, and 2 ng/mL EGF. Each sample was treated by adding 20 μL to achieve the desired concentration. The cells were incubated at 37℃ with 5% CO2 for 9 hours, then stained with 0.2% crystal violet solution. The extent of cell migration was observed and photographed under a microscope (Olympus IX53, 100x magnification).

Result

1. Cell cytotoxicity and NF-κB inhibition

To evaluate the effects of bioconverted Picrasma quassioides (B-P.Q) extract, untreated Picrasma quassioides extract (P.Q), and peony root bark extract (BOT)—which is recognized for its potent anti-inflammatory properties (Ekiert et al., 2022)—on NIH 3T3 fibroblast cell viability, we treated the cells with these extracts at various concentrations and assessed their viability. We tested B-P. Q and P.Q at concentrations of 50 and 500 μg/mL, and BOT at 50 μg/mL, with none showing cytotoxic effects. Therefore, further experiments were conducted using each extract at 50 μg/mL.
Based on the optimal response ratio identified from NF-κB activity inhibition experiments (which involved adding 2% kiwi and 2% pineapple to 10% Picrasma quassioides bark extract), we investigated the ideal reaction time. The extracts were reacted for 0, 1, 3, 7, and 14 days, and each mixture was tested on 3T3 cells to assess changes in NF-κB activity. As shown in Figure 1, the mixture reacted with sophora bark extract for 7 days demonstrated the highest NF-κB activity inhibition, surpassing even the peony root bark extract (BOT), which is recognized for its anti-inflammatory effects through NF-κB signaling pathway inhibition. Consequently, the optimal conditions for biological transformation were determined to be 10% Picrasma quassioides bark extract combined with 2% kiwi and 2% pineapple for 7 days. The resulting products were then filtered and freeze-dried (B-P.Q) for further use.

2. Measurement of NF-κB related signaling Protein Activation

To verify the anti-inflammatory effects of bioconverted Picrasma quassioides extract (B-P.Q), we measured the activation levels of NF-κB-related signaling proteins, such as p-p38, p-Akt-1, SAPK/JNK, and MEK1/2, which are involved in the inflammatory response. Inflammation was induced by treating with TNF-α and IL-1β. Preliminary experiments identified the peak of each signal at specific times, and the inhibition rates of each substance were confirmed. Changes in the activation of NF-κB-related signaling proteins were measured using the Sandwich ELISA kit (Cell Signaling, USA) according to the manual specified in the materials and methods section.

1) p-p38

p-p38 is a type of p38 MAP kinase with four isoforms: p38α, β, γ (ERK6, SAPK3), and δ (SAPK4). It is known to be activated by various intracellular stresses, including inflammatory cytokines, UV radiation, LPS, and growth factors (Raingeaud et al., 1995). Maximum activation of p-p38 is observed about 20 minutes after treating cells with TNF-α and IL-1β. Using this time frame, the effectiveness of each substance was assessed, as illustrated in Figure 2A. The group was treated only with TNF-α and IL-1β, using PBS as a substitute for the sample (positive control, P.C.) showed a 16.05-fold increase in p-p38 activation compared to the control group (N.C.). BOT reduced activation by 10.53% compared to the treatment group, while P.Q., without enzyme treatment, reduced it by 24.54%. B-P.Q., treated with the enzyme, achieved a 27.24% reduction, with significant differences between the enzyme-treated and untreated groups (p<0.05). This suggests that B-P.Q. may offer superior efficacy in reducing inflammatory responses, which is crucial for minimizing redness and irritation in cosmetic applications.

2) p-Akt-1

Akt, which influences IKK-α, β, and γ, is phosphorylated into p-Akt and plays a key role in activating NF-κB (Kim & Chung, 2002). The peak activation of p-Akt-1 occurs around 40 minutes after cells are exposed to TNF-α and IL-1β. At this time point, the efficacy of each substance was assessed, as shown in Figure 2B. The treatment group (P.C.) demonstrated a 2.57-fold increase in p-Akt-1 activation compared to the control group (N.C.). BOT reduced p-Akt-1 activation by 25.42% compared to the treatment group, while P.Q., which was not enzyme-treated, showed a 20.73% reduction. B-P.Q., treated with the enzyme, achieved a 31.28% reduction in activation. However, the difference in efficacy between enzyme-treated and untreated groups was not statistically significant. From a cosmetic perspective, the ability to reduce p-Akt-1 activation can contribute to improved skin appearance by potentially mitigating inflammatory responses and supporting overall skin health.

3) p-SAPK/JNK

SAPK/JNK, activated by environmental stress and various stimuli, plays a role in the activation of NF-κB and AP-1 (Chen et al., 2021). It operates through mechanisms triggered by stresses such as UV, mediated by MAPKs like ERK and JNK (Yang et al., 2018).
Cells exposed to TNF-α and IL-1β exhibit peak activation of p-SAPK/JNK at 20 minutes post-stimulation. Figure 2C displays the effectiveness of each substance at this time point. The treatment group (P.C.) showed a 17.26-fold increase in p-SAPK/JNK activation compared to the control group (N.C.). BOT reduced p-SAPK/JNK activation by 41.25% relative to the treatment group, while P.Q., which was not enzyme-treated, decreased activation by 36.62%. B-P.Q., which underwent enzyme treatment, achieved a 37.76% reduction. However, the difference in effectiveness between enzyme-treated and untreated groups was not statistically significant. From a cosmetic perspective, these results highlight the potential of these substances in modulating inflammatory pathways, which is crucial for improving skin conditions characterized by redness and irritation.

4) p-MEK1/2

MEK1 and MEK2, also known as MAPK or Erk kinases, are pivotal in signaling pathways that regulate cell growth and differentiation. Activated by various growth factors and cytokines, MEK1/2 play a crucial role in processes triggered by membrane depolarization and calcium influx (Alessi et al., 1994).
Cells exposed to TNF-α and IL-1β reach peak activation of p-MEK1/2 at 5 minutes after stimulation. Figure 2D illustrates the efficacy of each substance at this time point. The treatment group (P.C.) showed a 3.96-fold increase in p-MEK1/2 activation compared to the control group (N.C.). BOT decreased p-MEK1/2 activation by 15.01% relative to the treatment group, while P.Q., which was not enzyme-treated, reduced activation by 14.09%. B-P.Q., treated with the enzyme, resulted in a 9.44% reduction. Although B-P. Q.’s inhibitory effect was not prominent at the 5-minute mark, significant inhibition was observed from 10 to 80 minutes. From a cosmetic perspective, this indicates that B-P.Q may offer a delayed yet effective reduction in signaling pathways associated with inflammation, which is crucial for addressing issues such as skin redness and irritation.

5) p-iκB

TNF-α and IL-1β can trigger the phosphorylation of IκB (inhibitor of NF-κB), leading to its degradation. This event is a crucial step in the NF-κB signaling pathway, as phosphorylated IκB allows NF-κB to move into the nucleus, where it activates genes involved in inflammation, immune responses, and cell survival (Sivamaruthi et al., 2023). Therefore, inhibiting the phosphorylation of IκB effectively means blocking the NF-κB signaling pathway.
Cells exposed to TNF-α and IL-1β reached peak activation of p-IκB at 5 minutes after stimulation. Figure 3A demonstrates how each substance performed at this critical time point. The treatment group (P.C.) showed a 16.66-fold increase in activation compared to the control group (N.C.). The BOT reduced this activation by 20.10% relative to the treatment group, while P.Q., without enzyme treatment, achieved a 28.68% reduction. Enzyme-treated B-P.Q. achieved a 42.91% reduction, although the difference in effectiveness between enzyme-treated and untreated groups did not reach statistical significance. This data suggests that B-P.Q. may have notable potential for reducing inflammatory responses related to skin conditions, which is significant for cosmetic applications targeting redness and inflammation.

6) p-Stat3

Stat3 is a key signaling protein frequently elevated in tumor sites, highlighting its role as an oncogene and anti-apoptotic factor. Beyond its involvement in oncogene regulation, Stat3 is also crucial for cellular defense against primary inflammatory responses (Yu et al., 2009). In the NF-κB signaling context, inhibiting Stat3 is considered an important strategy for managing inflammatory responses and targeting chronic skin conditions like psoriasis (Andrés et al., 2013). In this experimental model (Figure 3B), while no significant changes were observed across the groups, B-P.Q. generally showed lower values compared to others.
Other cytokines and transcription factors:
NF-κB is made up of five protein types: the p50 subunit family (p50, p52) and the p65 subunit family (p65, c-Rel, RelB). These proteins can form either homodimers (such as p50-p50 or p65-p65) or heterodimers (such as p50-p65 or p50-Rel). Typically, NF-κB is composed of p50-p65 heterodimers. Therefore, changes in NF-κB activity are more influenced by the location of p65 rather than its quantity. As shown in Figure 3C, the amount of p65 remained consistent, indicating no significant changes. Similarly, Figures 3D show that the levels of Akt-1 was stable throughout the experimental period. This series of results suggests that the NF-κB-related experiments were conducted accurately, providing reliable insights into their potential cosmetic applications.

3. Chorioallantoic membrane assay results

The chorioallantoic membrane (CAM), which rapidly develops new blood vessels during the embryonic development of fertilized eggs, is utilized in CAM assays to evaluate angiogenesis inhibition. In this widely used method, the CAM acts as the site for assessing new blood vessel formation. To confirm normal vascular conditions, a cover slip is placed on the CAM without any substances, and the area is observed after 3 days (Ribatti, 2008). Substances that inhibit new blood vessel formation in the CAM area are reported to have potential as treatments for chronic skin inflammation. From a cosmetic perspective, reducing inflammation is highly important (Auerbach et al., 2003). Recent studies have confirmed the antiangiogenic effects of seven natural substances, including garlic, ginseng, and rosemary, while other substances like turmeric have been reported to promote blood vessel formation (Kim et al., 2008). These compounds are used in cosmetics for their important roles as anti-inflammatory agents and for reducing redness. Research into the role of natural substances in inhibiting new blood vessel formation is ongoing. In this study, we used CAM assays to compare the anti-angiogenic effects of bioconverted B-P.Q and non-bioconverted P.Q extracts to assess their potential for treating chronic inflammatory skin conditions. Both extracts were tested at a concentration of 50 μg/mL, similar to the conditions used in NF-κB-related signaling protein assays. As shown in Figure 4, while P.Q inhibited angiogenesis compared to the control group treated with PBS, B-P.Q demonstrated a significantly greater suppression of new blood vessel formation. This confirms the potent antiangiogenic effect of B-P.Q.. The anti-angiogenic effect is closely linked to reducing skin redness, making it highly significant from a cosmetic perspective.

4. Tube formation inhibition assay results

Endothelial cells (HUVECs) proliferate and grow invasively to form inflammatory tissues, differentiate into endothelial cells, and ultimately form blood vessels (Kocherova et al., 2019). To evaluate the anti-inflammatory effects of various substances, we performed a tube formation assay to assess endothelial cell differentiation. HUVECs were treated with angiogenic factors βFGF and EGF, and B-P.Q. was applied at a concentration of 50 μg/mL under identical conditions. As depicted in Figure 5, the bioconverted Picrasma quassioides extract (B-P.Q.) effectively inhibited tube formation. This finding confirms B-P.Q.’s anti-angiogenic properties, which are highly relevant for reducing redness and irritation in cosmetic formulations.

5. HUVECs cell migration inhibition assay results

HUVECs, which are derived from umbilical cord veins, play a key role in migrating to sites where new blood vessels form or existing vessels are damaged. Inhibiting their migration can be beneficial for treating chronic inflammatory skin conditions like psoriasis and atopic dermatitis(García-Caballero et al., 2011), as these diseases often involve excessive angiogenesis. Therefore, controlling angiogenesis and cell migration is crucial for managing such conditions.
To investigate the potential benefits of bioconverted Picrasma quassioides extract (B-P.Q.), we conducted an experiment to assess its effect on endothelial cell migration. Using human umbilical vein endothelial cells (HUVECs) stimulated with βFGF (2 ng/mL) and EGF (2 ng/mL), we treated the cells with B-P.Q. at a concentration of 50 μg/mL. The results, illustrated in Figure 6, showed that B-P. Q. effectively inhibited the migration of these cells, which is a crucial step in new blood vessel formation. This finding suggests that B-P.Q. could be highly beneficial in cosmetics for reducing excessive blood vessel formation, which is often associated with redness and irritation. By incorporating B-P.Q. into skincare formulations, it may improve the appearance of chronic inflammatory conditions, making it a valuable ingredient for enhancing skin health and reducing unwanted redness.

Discussion

The study provides valuable insights into the potential applications of bioconverted Picrasma quassioides extract (B-P.Q.) for managing skin inflammation and improving skin conditions.

Key Points for Cosmetic Applications:

1. Anti-Inflammatory Effects: NF-κB-Related Signaling Proteins: The study reveals that B-P.Q. significantly reduces the activation of key inflammatory signaling proteins such as p-p38, p-Akt-1, p-SAPK/JNK, and p-IκB compared to other treatments. In cosmetics, reducing these inflammatory markers can help minimize skin redness and irritation, leading to a more even and calm complexion (Seo et al., 2014). While both BOT and P.Q. show some anti-inflammatory effects, B-P.Q. generally demonstrates superior efficacy. This suggests that B-P.Q. might be more effective in formulations aimed at reducing inflammation and redness. Anti-inflammatory effects are not limited to this study. For instance, traditional Chinese medicines that inhibit p38 also have melanin production suppression capabilities (Tsang et al., 2012). Additionally, inhibiting p-SAPK/JNK is highly effective in combating wrinkles. For instance, JNK/SAPK signaling is crucial for the efficient reprogramming of human fibroblasts (Neganova et al., 2016). This suggests that anti-inflammatory effects can be utilized to address various skin issues.
2. Anti-Angiogenic Properties: B-P.Q. shows a greater suppression of new blood vessel formation compared to P.Q., indicating a strong anti-angiogenic effect. This is particularly relevant for reducing visible redness and inflammation in cosmetic products, as excessive blood vessel formation can exacerbate these issues (Seo et al., 2014). B-P.Q. inhibits tube formation and cell migration in endothelial cells, which is beneficial for managing chronic inflammatory skin conditions like psoriasis and atopic dermatitis. By controlling angiogenesis and cell migration, B-P.Q. could help in reducing the appearance of redness and irritation in cosmetic applications. Genistein was the most potent inhibitor of angiogenesis among the isoflavone compounds tested (Su et al., 2005). Genistein suppresses wrinkles and inflammation caused by UV exposure (Tang et al., 2022), so these effects are closely interconnected.

Practical Implications for Cosmetic Formulations:

1. Redness and Irritation Control: Incorporating B-P. Q. into cosmetic products could provide anti-inflammatory benefits, helping to reduce skin redness and irritation. This would be valuable in products designed for sensitive skin or those targeting conditions like rosacea. Chronic inflammation, a hallmark of rosacea, can cause a variety of symptoms such as flushing, telangiectasia, inflammatory papules and pustules, and ocular manifestations. Therefore, managing rosacea is critically important from an aesthetic perspective (Paiva-Santos et al., 2023).
2. Overall Skin Health: The ability of B-P.Q. to modulate inflammatory pathways and inhibit angiogenesis suggests it could support overall skin health, making it a promising ingredient for skincare lines focused on calming and protecting the skin. Hesperidin is a citrus flavanone glycoside with strong anti-inflammatory properties that inhibits UVB-induced angiogenesis in the skin (Kim et al., 2021). And acts as a promising skincare bioactive (Rodrigues & Pintado, 2024). Hesperidin can counteract UV effects by reducing epidermal thickening, regulating angiogenesisrelated factors (such as PI3K/Akt, VEGF, HIF-1α, and MMPs), modulating apoptotic proteins triggered by oxidative stress, and affecting immune cells and inflammatory cytokines, which helps decrease inflammation.
3. Potential for New Products: The data supports the development of new cosmetic products featuring B-P.Q. as a key ingredient. These products could be marketed for their advanced anti-inflammatory and anti-angiogenic properties, potentially differentiating them from existing offerings in the market. Plants with anti-inflammatory and anti-angiogenic properties sometimes have skin whitening effects (Jung et al., 2013). Plants with both anti-inflammatory and anti-angiogenic properties not only contribute to skin whitening but are also valuable for overall skin health. Unlike simple anti-inflammatory agents, angiogenesis inhibitors can significantly enhance skin beauty by preventing the formation of new blood vessels that contribute to chronic, inflammatory skin conditions (Lee et al., 2021). Since such conditions negatively impact skin appearance, these ingredients are likely to play a key role in improving aesthetic outcomes and promoting a healthier, more beautiful complexion.

Conclusion

In summary, B-P.Q.'s proven ability to reduce inflammation and inhibit angiogenesis underscores its potential as a powerful ingredient in cosmetics designed to treat redness, irritation, chronic inflammatory skin conditions, and a variety of other skin health issues.

NOTES

Author's contribution
K.S.S., J.H.L., H.O., H.C.K., W.S. contributed to this work. However, K.S.S. designed all experimental investigations. Y.W.K. and S.H.B. oversaw the project and contributed to all aspects of analysis and experimental design.
Author details
Kyeong-Seok So (PhD program), Research Institute for Molecular-Targeted Drugs, Konkuk University,120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea; John Hwan Lee (Research director), Technology Research Institute, Gunpo Campus, CNF,29, Gongdan-ro 140 beonan-gil, Gunpo-si, Gyeonggi-do 15845, Korea; Hanna Oh (Deputy Manager), Marketing Research and Development Department, JW Pharmaceutical, 38 Gwacheon-daero 7-gil, Gwacheon-si, Gyeonggi-do 13840, Korea. Hee-Cheol Kang (CEO) and Wonsang Seo (Director) are associated with the Materials Division Affiliated Research Center, GFC Life Science,823 Dongtansunhwan-daero, Hwaseong-si, Gyeonggi-do 18471, Korea; Yong-Woo Kim (PhD program), Department of Chemical and Biological Engineering, Dongguk University, 30 Pildong-ro 1-gil, Jung-gu, Seoul 04620, Korea; Seunghee Bae (Professor), Research Institute for Molecular-Targeted Drugs, Konkuk University,120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea.

Figure 1.

Activation of NF-κB and the inhibitory effect of various samples in NIH 3T3 cells.

N.C., negative control; P.C., positive control (PBS); P.Q.: Picrasma quassioides extract; Bot, peony root bark extract; D-#, where# indicates the enzyme treatment time for pineapple and kiwi. D-7 is B-P.Q. Significant differences compared to N.C.: ***p<0.001. Significant differences compared to P.C.: ##p<0.01, ###p<0.001.
ajbc-22-3-447f1.jpg
Figure 2.

Increase or Decrease of various cytokines and the inhibitory effect of different samples in NIH 3T3 cells treated with TNF-α and IL-1β.

(A) p-p38; (B) p-Akt-1; (C) p-SAPK/JNK; (D) p-MEK ½. P.Q., Picrasma quassioides extract; Bot, peony root bark extract; B-P.Q., Bioconverted Picrasma quassioides extract. Significant differences were observed compared to N.C. Significant differences between groups: *p<0.05.
ajbc-22-3-447f2.jpg
Figure 3.

Modulation of cytokine levels and inhibitory effects of diverse samples in TNF-α and IL-1β-stimulated NIH 3T3 cells.

(A) p-ikB; (B) p-Stat 3; (C) p65; (D) Akt-1, P.C., Positive control (PBS), P.Q., Picrasma quassioides extract, Bot, Peony root bark extract; B-P.Q., Bioconverted Picrasma quassioides extract. Significant differences were observed compared to N.C.
ajbc-22-3-447f3.jpg
Figure 4.

Effect of B-P.Q on angiogenesis in chick chorioallantoic membrane (CAM).

The CAM was visualized using fat emulsion after sample implantation: (A) PBS (phosphate-buffered saline); (B) P.Q (50 μg/mL) (Picrasma quassioides extract); (C) B-P.Q (50 μg/mL) (Bioconverted Picrasma quassioides extract).
ajbc-22-3-447f4.jpg
Figure 5.

Effect of B-P.Q on endothelial tube formation in βFGF plus EGF-treated HUVEC cells.

(A) PBS (phosphate-buffered saline); (B) βFGF 2 ng/mL+EGF 2 ng/mL; (C) 50 μg/mL B-P.Q+(βFGF 2 ng/mL+EGF 2ng/mL). B-P. Q. stands for bioconverted Picrasma quassioides extract. βFGF refers to beta fibroblast growth factor, and EGF denotes epidermal growth factor.
ajbc-22-3-447f5.jpg
Figure 6.

Effect of B-P.Q on endothelial cell migration in βFGF plus EGF-treated HUVEC cells.

(A) PBS (phosphate-buffered saline); (B) βFGF 2 ng/mL+EGF 2 ng/mL; (C) 50 μg/mL B-P.Q+(βFGF 2 ng/mL+EGF 2 ng/mL). B-P.Q. refers to Bioconverted Picrasma quassioides extract. PBS stands for phosphate buffered saline, βFGF denotes beta fibroblast growth factor, and EGF signifies epidermal growth factor.
ajbc-22-3-447f6.jpg
Table 1.
List of the ELISA kits used in this study
Groups Phosphorylated site Function Cat.No
PathScan Phospho-p38 MAPK Sandwich ELISA Kit Thr180/Tyr182 Activated by cellular stress #7946
PathScan Phospho-Akt1 Sandwich ELISA Kit Ser473 Directly induce IKKs #7160
PathScan Phospho-SAPK/JNK Sandwich ELISA Kit Thr183/Tyr185 Directly induce NF-κB, AP-1 #7325
PathScan Phospho-MEK1 Sandwich ELISA Kit Ser217/Ser221 Activated by growth factor #7175
PathScan Phospho-Stat3 Sandwich ELISA Kit Tyr705 Inflammation modulator #7300
PathScan Phospho-IκB-α Sandwich ELISA Kit Ser32 Subunit of NF-κB #7355

References

Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A, Marshall CJ, Cowley S. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. The EMBO Journal 13: 1610-1619. 1994.
crossref pmid pmc pdf
Andrés RM, Montesinos MC, Navalón P, Payá M, Terencio MC. NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH. Journal of Investigative Dermatology 133: 2362-2371. 2013.
crossref pmid
Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: a critical overview. Clinical Chemistry 49: 32-40. 2003.
crossref pmid pdf
Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Archives of Pharmacal Research 27: 61-67. 2004.
crossref pmid pdf
Chen J, Ye C, Wan C, Li G, Peng L, Peng Y, Fang R. The roles of c-Jun N-terminal kinase (JNK) in infectious diseases. International Journal of Molecular Sciences 22: 9640. 2021.
crossref pmid pmc
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9: 7204-7218. 2018.
crossref pmid pmc
Ekiert H, Klimek-Szczykutowicz M, Szopa A. Paeonia × suffruticosa (Moutan Peony)-a review of the chemical composition, traditional and professional use in medicine, position in cosmetics industries, and biotechnological studies. Plants (Basel) 11: 3379. 2022.
crossref pmid pmc
García-Caballero M, Marí-Beffa M, Medina MA, Quesada AR. Dimethylfumarate inhibits angiogenesis in vitro and in vivo : a possible role for its antipsoriatic effect? Journal of Investigative dermatology 131: 1347-1355. 2011.
crossref pmid
Ginwala R, Bhavsar R, Chigbu DI, Jain P, Khan ZK. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants 8: 35. 2019.
crossref pmid pmc
Jiang S, Zhang D, Huang H, Lei Y, Han Y, Han W. Extracellular signal-regulated Kinase 5 is required for low-concentration H2O2-induced angiogenesis of human umbilical vein endothelial cells. Biomed Research International 2017: 6895730. 2017.
crossref pmid pmc pdf
Jung HJ, Cho YW, Lim HW, Choi H, Ji DJ, Lim CJ. Antiinflammatory, antioxidant, anti-angiogenic and skin whitening activities of Phryma leptostachya var. asiatica Hara extract. Biomolecular & Therapeutics 21: 72-78. 2013.
crossref pmid pmc
Kim D, Chung JK. Akt: versatile mediator of cell survival and beyond. Journal of Biochemistry and Molecular Biology 35: 106-115. 2002.
crossref pmid
Kim DJ, Park BK, Lee YW, Yoo HS, Han SS, Cho CG. Effects of Bikihuan (BKH) on anti-angiogenesis. Journal of Korean Traditional Oncology 13: 13-24. 2008.

Kim KM, Im AR, Lee JY, Kim T, Ji KY, Park DH, Chae S. Hesperidin inhibits UVB-induced VEGF production and angiogenesis via the inhibition of PI3K/Akt pathway in HR-1 hairless mice. Biological and Pharmaceutical Bulletin 44: 1492-1498. 2021.
pmid
Kocherova I, Bryja A, Mozdziak P, Angelova Volponi A, Dyszkiewicz-Konwińska M, Piotrowska-Kempisty H, Antosik P, Bukowska D, Bruska M, Iżycki D. Human umbilical vein endothelial cells (HUVECs) co-culture with osteogenic cells: from molecular communication to engineering prevascularised bone grafts. Journal of Clinical Medicine 8: 1602. 2019.
crossref pmid pmc
Lee HJ, Hong YJ, Kim M. Angiogenesis in chronic inflammatory skin disorders. International Journal of Molecular Sciences 22: 12035. 2021.
crossref pmid pmc
Lee SJ. Novel natural products as active material for beauty food. Food Science and Industry 40: 10-18. 2017.

Lundberg IE. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies. Current Rheumatology Reports 2: 216-224. 2000.
crossref pmid pdf
Mohd Jamil MDH, Taher M, Susanti D, Rahman MA, Zakaria ZA. Phytochemistry, traditional use and pharmacological activity of Picrasma quassioides : a critical reviews. Nutrients 12: 2584. 2020.
crossref pmid pmc
Neganova I, Shmeleva E, Munkley J, Chichagova V, Anyfantis G, Anderson R, Passos J, Elliott DJ, Armstrong L, Lako M. JNK/SAPK Signaling is essential for efficient reprogramming of human fibroblasts to induced pluripotent stem cells. Stem Cells 34: 1198-1212. 2016.
crossref pmid pmc pdf
Paiva-Santos AC, Gonçalves T, Peixoto D, Pires PC, Velsankar K, Jha NK, Chavda VP, Mohammad IS, Cefali LC, Mazzola PG, et al. Rosacea topical treatment and care: from traditional to new drug delivery systems. Molecular Pharmaceutics 20: 3804-3828. 2023.
crossref pmid pmc pdf
Pérez-Rivero C, López-Gómez JP. Unlocking the potential of fermentation in cosmetics: a review. Fermentation 9: 463. 2003.
crossref
Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. Journal of Biological Chemistry 270: 7420-7426. 1995.
crossref pmid
Ribatti D. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. International Review of Cell and Molecular Biology 270: 181-224. 2008.
pmid
Rodrigues CV, Pintado M. Hesperidin from orange peel as a promising skincare bioactive: an overview. International Journal of Molecular Sciences 25: 1890. 2024.
crossref pmid pmc
Seo WS, Oh HN, Park WJ, Um SY, Lee DW, Kang SM. Study on the anti-inflammatory effect and mechanism of Prunus mume extract regarding NF-κB. KSBB Journal 29: 50-57. 2014.
crossref
Sivamaruthi BS, Raghani N, Chorawala M, Bhattacharya S, Prajapati BG, Elossaily GM, Chaiyasut C. NF-κB pathway and its inhibitors: a promising frontier in the management of Alzheimer's disease. Biomedicines 11: 2587. 2023.
crossref pmid pmc
Strbo N, Yin N, Stojadinovic O. Innate and adaptive immune responses in wound epithelialization. Advances in Wound Care 3: 492-501. 2014.
crossref pmid pmc
Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH. The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochemical Pharmacology 69: 307-318. 2005.
crossref pmid
Tang SC, Hsiao YP, Ko JL. Genistein protects against ultraviolet B-induced wrinkling and photoinflammation in in vitro and in vivo models. Genes & Nutrition 17: 4. 2022.
crossref pmid pmc pdf
Tsang TF, Ye Y, Tai WCS, Chou GX, Leung AKM, Yu ZL, Hsiao WLW. Inhibition of the p38 and PKA signaling pathways is associated with the anti-melanogenic activity of Qianwang-hong-bai-san, a Chinese herbal formula, in B16 cells. Journal of Ethnopharmacology 141: 622-628. 2012.
crossref pmid
Willke T, Vorlop KD. Industrial bioconversion of renewable resources as an alternative to conventional chemistry. Applied Microbiology and Biotechnology 66: 131-142. 2004.
crossref pmid pdf
Yang A, Suh WI, Kang NK, Lee B, Chang YK. MAPK/ERK and JNK pathways regulate lipid synthesis and cell growth of Chlamydomonas reinhardtii under osmotic stress, respectively. Scientific Reports 8: 13857. 2018.
crossref pmid pmc pdf
Yoshikawa K, Sugawara S, Arihara S. Phenylpropanoids and other secondary metabolites from fresh fruits of Picrasma quassioides. Phytochemistry 40: 53-256. 1995.
crossref
Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Reviews Cancer 9: 98-809. 2009.
crossref pmid pmc pdf
TOOLS
PDF Links  PDF Links
PubReader  PubReader
ePub Link  ePub Link
Full text via DOI  Full text via DOI
Download Citation  Download Citation
  E-Mail
  Print
Share:      
METRICS
0
Crossref
455
View
20
Download
Related article
Editorial Office
No. 1505, 1506, 3rd Ace High-End Tower, 145, Gasan digital 1-ro, Geumcheon-gu, Seoul 08506, Korea
TEL: +82-2-6957-8155   FAX: +82-502-770-2278   E-mail: ajbc.edit@e-ajbc.org
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korea Institute of Dermatological Sciences.                 Developed in M2PI